Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Voprosy Onkologii|November 20, 2018
[Specific features of drug sensitivity of hereditary cancers]E N ImyanitovVoprosy Onkologii|January 30, 2019
[Whole exome sequencing in oncology]E N Suspitsyn, A P Sokolenko, E N ImyanitovVoprosy Onkologii|January 30, 2019
[CHEK2-associated hereditary breast cancer]A A Bessonov, A G Iyevleva, E N Imyanitov, et al.International Journal of Cancer|January 2, 1993
Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancerP G Knyazev, E N Imyanitov, O I Chernitsa, et al.Arkhiv Patologii|October 22, 2015
[Immunohistochemical and genetic profiles of melanomas with spindle cell morphology]V A Heinstein, A G Ievleva, E N Imyanitov, et al.Oncology|January 1, 1992
Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSRP G Knyazev, E N Imyanitov, O I Chernitca, et al.Cancer Letters|October 26, 1999
Features of HPV infection among the healthy attendants of gynecological practice in St. Petersburg, RussiaY N Alexandrova, A A Lyshchov, N R Safronnikova, et al.Neoplasma|January 1, 1993
Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patientsE N Imyanitov, O I Chernitsa, O M Serova, et al.Voprosy Onkologii|November 18, 2015
[Acral lentiginous melanoma: the current state of the problem]M Yu Myasnyankin, G I Gafton, V V Anisimov, et al.Annals of Hematology|March 23, 2001
HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemiaS I Kapustin, T I Popova, A A Lyshchov, et al.Pageof 4